Noah Lechtzin

Noah Lechtzin

Pulmonary Medicine

601 North Caroline Street
Floor 5
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Home Spirometry.

Home Spirometry.

Journal: Clinics in chest medicine

Published: August 06, 2025

Dynamic 11C-Para-Aminobenzoic Acid Positron Emission Tomography/Computed Tomography for Visualizing Pulmonary Mycobacteroides abscessus Infections.

Dynamic 11C-Para-Aminobenzoic Acid Positron Emission Tomography/Computed Tomography for Visualizing Pulmonary Mycobacteroides abscessus Infections.

Journal: American journal of respiratory and critical care medicine

Published: March 28, 2025

Provider Practices in Pulmonary Exacerbations of Cystic Fibrosis in the Era of Highly Effective Modulator Therapy.

Provider Practices in Pulmonary Exacerbations of Cystic Fibrosis in the Era of Highly Effective Modulator Therapy.

Journal: Annals of the American Thoracic Society

Published: March 05, 2025

Racial disparities in lung transplantation for cystic fibrosis in the era of highly effective modulator therapy.

Racial disparities in lung transplantation for cystic fibrosis in the era of highly effective modulator therapy.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: May 08, 2024

Establishment of a conditionally reprogrammed primary eccrine sweat gland culture for evaluation of tissue-specific CFTR function.

Establishment of a conditionally reprogrammed primary eccrine sweat gland culture for evaluation of tissue-specific CFTR function.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: February 21, 2024

Maternal and fetal outcomes in multiparous women with Cystic Fibrosis.

Maternal and fetal outcomes in multiparous women with Cystic Fibrosis.

Journal: Respiratory medicine

Published: October 29, 2023

Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force.

Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: October 11, 2023

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis.

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis.

Journal: iScience

Published: September 18, 2023

COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.

COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: May 31, 2023

Telemedicine and remote monitoring in cystic fibrosis.

Telemedicine and remote monitoring in cystic fibrosis.

Journal: Current opinion in pulmonary medicine

Published: May 09, 2023

Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS.

Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS.

Journal: Journal of medical economics

Published: March 17, 2023

The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis.

The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis.

Journal: Heliyon

Published: March 08, 2023

Showing 1-12 of 81

Last Updated: 09/26/2026